• FirefoxInstall the new Firefox »
  •  Dow Up 0.21% Nasdaq Up 0.32%

    Curis, Inc. (CRIS)

    -NasdaqGM
    3.33 Up 0.17(5.38%) Mar 5, 3:59PM EST
    Add to Portfolio
    Prev Close:3.16
    Open:3.16
    Bid:2.76 x 2700
    Ask:3.49 x 600
    1y Target Est:5.00
    Beta:1.6
    Earnings Date:May 6 - May 11 (Est.)
    Day's Range:3.14 - 3.35
    52wk Range:1.09 - 3.50
    Volume:2,334,313
    Avg Vol (3m):1,459,490
    Market Cap:343.58M
    P/E (ttm):N/A
    EPS (ttm):-0.22
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CRISUp 5.38%343.58M
    EXELUp 1.97%607.12M
    INFIUp 2.10%807.67M
    PFEDown 0.49%211.26B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):33.12
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.27
    Quarterly EPS Est (Mar-15) :-0.06
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Curis, Inc. is engaged in the research, development, and commercialization of cancer therapeutics. It focuses on developing cancer drug candidates, including CUDC-907, an oral, small molecule drug candidate that is designed to inhibit histone deac... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback